Update shared on10 Oct 2025
Fair value Increased 1.11%Analysts have raised BWX Technologies' fair value price target by $2.10 to $192.10. They cite the company's strong positioning in both nuclear defense and merchant nuclear power markets as key drivers for the upward revision.
Analyst Commentary
Recent analyst research highlights renewed optimism surrounding BWX Technologies, with upward price target adjustments and newly initiated positive coverage. The company's strategic participation in both defense and commercial nuclear power markets continues to inform analyst perspectives on its long-term value and execution potential.
Bullish Takeaways- Exposure to large nuclear defense programs ensures a stable and recurring revenue base, supporting long-term business sustainability.
- The company's positioning as a leading merchant supplier to the nuclear power industry creates significant upside opportunities for growth, particularly as nuclear power demand increases.
- BWX Technologies is considered capable of navigating both offensive growth initiatives and defensive market challenges, which contributes to bullish valuation upgrades.
- Continued high demand for naval nuclear power plants solidifies the company’s role in supporting key military and space nuclear deployments, enhancing its competitive advantage and perceived value.
What's in the News
- BWX Technologies was awarded a $1.5 billion U.S. sole-source enrichment contract for establishing domestic uranium enrichment capability. Construction is underway on its Centrifuge Manufacturing Development Facility in Oak Ridge, Tennessee (Bloomberg).
- The company secured a 10-year, $1.6 billion contract from the Department of Energy's National Nuclear Security Administration to build a high-purity depleted uranium manufacturing plant in Jonesborough, Tennessee. The project is expected to create around 175 highly skilled jobs.
- BWXT announced the commencement of fabrication for the Pele microreactor's core at its Lynchburg, Virginia campus. This demonstration microreactor for the Department of Defense is designed to provide transportable, resilient power beginning in 2028.
- The company was awarded approximately $2.6 billion in contracts to manufacture naval nuclear reactor components for Virginia and Columbia-class submarines and Ford-class aircraft carriers. Deliveries are expected over the next six to eight years.
- BWXT reached a new milestone in manufacturing advanced TRISO nuclear fuel, enhancing its capability to supply next-generation fuel for advanced nuclear reactors and supporting critical Department of Energy demonstration projects.
Valuation Changes
- Fair Value Price Target: Increased from $190.00 to $192.10, reflecting a modest upward adjustment in long-term expectations.
- Discount Rate: Increased slightly from 7.83 percent to 7.85 percent, indicating a minor change in risk assumptions.
- Revenue Growth: Expected annual growth rate has risen from 11.15 percent to 11.44 percent, suggesting an improved future sales outlook.
- Net Profit Margin: Marginally decreased from 12.58 percent to 12.48 percent, reflecting slightly lower profit expectations.
- Future P/E Ratio: Projected future price-to-earnings ratio has increased from 43.82x to 44.32x, indicating a slight rise in anticipated valuation multiples.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.